Use of medical emergency team (MET) responses to detect medical errors.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMC 1743873)

Published in Qual Saf Health Care on August 01, 2004

Authors

R S Braithwaite1, M A DeVita, R Mahidhara, R L Simmons, S Stuart, M Foraida, Medical Emergency Response Improvement Team (MERIT)

Author Affiliations

1: 200 Lothrop Street, Pittsburgh, PA 15213, USA.

Articles citing this

The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care (2008) 6.79

Learning from mistakes. Factors that influence how students and residents learn from medical errors. J Gen Intern Med (2006) 1.45

Utility of commonly captured data from an EHR to identify hospitalized patients at risk for clinical deterioration. AMIA Annu Symp Proc (2007) 1.25

Mature rapid response system and potentially avoidable cardiopulmonary arrests in hospital. Qual Saf Health Care (2007) 1.21

Bench-to-bedside review: The MET syndrome--the challenges of researching and adopting medical emergency teams. Crit Care (2008) 1.07

Medical emergency teams: deciphering clues to crises in hospitals. Crit Care (2005) 1.05

Using Medical Emergency Teams to detect preventable adverse events. Crit Care (2009) 1.00

Crises in clinical care: an approach to management. Qual Saf Health Care (2005) 0.96

Rapid response systems in acute hospital care. Ann Thorac Med (2010) 0.91

Improved clinical outcomes combining house staff self-assessment with an audit-based quality improvement program. J Gen Intern Med (2010) 0.87

Clinical criteria to screen for inpatient diagnostic errors: a scoping review. Diagnosis (Berl) (2015) 0.83

Deployment of rapid response teams by 31 hospitals in a statewide collaborative. Jt Comm J Qual Patient Saf (2015) 0.78

The evolving story of medical emergency teams in quality improvement. Crit Care (2009) 0.76

Rapid Response Teams: Policy Implications and Recommendations for Future Research. J Nurs Law (2008) 0.75

Baseline hospital performance and the impact of medical emergency teams: modelling vs. conventional subgroup analysis. Trials (2009) 0.75

A Survey of Hospitals That Participated in a Statewide Collaborative to Implement and Sustain Rapid Response Teams. J Healthc Qual (2016) 0.75

Articles cited by this

Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med (1991) 38.78

The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med (1991) 26.50

Reporting and preventing medical mishaps: lessons from non-medical near miss reporting systems. BMJ (2000) 9.35

Framework for analysing risk and safety in clinical medicine. BMJ (1998) 9.32

What practices will most improve safety? Evidence-based medicine meets patient safety. JAMA (2002) 7.53

Deaths due to medical errors are exaggerated in Institute of Medicine report. JAMA (2000) 7.05

Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc (1998) 6.21

Rates of in-hospital arrests, deaths and intensive care admissions: the effect of a medical emergency team. Med J Aust (2000) 5.28

Patient safety efforts should focus on medical injuries. JAMA (2002) 4.66

System changes to improve patient safety. BMJ (2000) 4.16

The Medical Emergency Team. Anaesth Intensive Care (1995) 3.92

Recognising clinical instability in hospital patients before cardiac arrest or unplanned admission to intensive care. A pilot study in a tertiary-care hospital. Med J Aust (1999) 3.76

Income inequality and population health. BMJ (2002) 3.34

Use of medical emergency team responses to reduce hospital cardiopulmonary arrests. Qual Saf Health Care (2004) 3.00

Incidence, location and reasons for avoidable in-hospital cardiac arrest in a district general hospital. Resuscitation (2002) 2.97

The Medical Emergency Team (MET): a model for the district general hospital. Aust N Z J Med (1998) 2.89

Human error in hospitals and industrial accidents: current concepts. J Am Coll Surg (2000) 2.69

Safe but sound: patient safety meets evidence-based medicine. JAMA (2002) 2.65

Diagnosing "vulnerable system syndrome": an essential prerequisite to effective risk management. Qual Health Care (2001) 2.60

The patient-at-risk team: identifying and managing seriously ill ward patients. Anaesthesia (1999) 2.43

Patient safety efforts should focus on medical errors. JAMA (2002) 2.39

Preventable medical injuries in older patients. Arch Intern Med (2000) 2.33

The identification of risk factors for cardiac arrest and formulation of activation criteria to alert a medical emergency team. Resuscitation (2002) 2.24

Human error in medicine: promise and pitfalls, part 2. Ann Emerg Med (2000) 1.61

Disclosure and prevention of medical errors. Committee on Bioethical Issues of the Medical Society of the State of New York. Arch Intern Med (2000) 1.20

Human error in emergency medicine. Ann Emerg Med (1999) 0.87

Articles by these authors

Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol (1975) 8.06

Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer (1979) 5.60

Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science (1992) 3.80

Replication program of active and inactive multigene families in mammalian cells. Mol Cell Biol (1988) 3.55

Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med (1992) 3.42

Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) (1980) 3.42

Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients. Nature (1990) 3.30

Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A (1993) 3.24

Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg (1983) 3.15

Use of medical emergency team responses to reduce hospital cardiopulmonary arrests. Qual Saf Health Care (2004) 3.00

A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med (1989) 2.78

Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus. Gastroenterology (1999) 2.75

Efficacy of interpersonal psychotherapy for postpartum depression. Arch Gen Psychiatry (2000) 2.58

Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med (1989) 2.49

Immunodepression after major surgery in normal patients. Surgery (1975) 2.48

Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci U S A (1993) 2.46

Pancreatico-duodenal allotransplantation: experimental and clinical experience. Ann Surg (1970) 2.44

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44

The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation (1987) 2.40

Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation (1985) 2.34

Clonal analysis of Escherichia coli O2:K1 isolated from diseased humans and animals. Infect Immun (1986) 2.27

An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med (1989) 2.27

Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res (1981) 2.25

Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg (1991) 2.24

Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis (1988) 2.16

Recommendations for end-of-life care in the intensive care unit: The Ethics Committee of the Society of Critical Care Medicine. Crit Care Med (2001) 2.12

Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol (1990) 2.11

Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol (1991) 2.07

Chemiluminescence response of phagocytizing human monocytes. Infect Immun (1976) 2.01

Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. Ann Surg (1998) 2.00

Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83

Pancreatic trauma: a review. Surgery (1972) 1.81

Antiserum to lymphocytes: prolonged survival of canine renal allografts. Science (1966) 1.81

Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79

Rate of replication of the murine immunoglobulin heavy-chain locus: evidence that the region is part of a single replicon. Mol Cell Biol (1987) 1.77

Chemiluminescence response of human leukocytes: influence of medium components on light production. Infect Immun (1977) 1.77

Family tension in the search for a kidney donor. JAMA (1971) 1.77

Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J Immunol (1990) 1.76

Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg (1990) 1.74

Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci U S A (1996) 1.71

Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet (1972) 1.71

Reactive nitrogen intermediates suppress the primary immunologic response to Listeria. J Immunol (1993) 1.69

Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology (2000) 1.69

Inducible cytosolic enzyme activity for the production of nitrogen oxides from L-arginine in hepatocytes. Biochem Biophys Res Commun (1990) 1.67

Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65

Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation. Pediatr Nephrol (1994) 1.55

Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol (1991) 1.54

Inhibition of chemotaxis Ng-monomethyl-L-arginine: a role for cyclic GMP. Blood (1989) 1.53

Hemorrhagic shock. Curr Probl Surg (1995) 1.53

The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation. Surgery (1981) 1.53

Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J Immunol (1996) 1.53

Mechanisms of microbial synergy in polymicrobial surgical infections. Rev Infect Dis (1985) 1.51

Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood (1994) 1.49

Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis. FASEB J (1991) 1.48

Estimation and characterization of the potential renal organ donor pool in Pennsylvania. Report of the Pennsylvania Statewide Donor Study. Transplantation (1991) 1.46

Role of anaerobic flora in the translocation of aerobic and facultatively anaerobic intestinal bacteria. Infect Immun (1987) 1.46

Evidence that rat Kupffer cells stimulate and inhibit hepatocyte protein synthesis in vitro by different mechanisms. Gastroenterology (1989) 1.45

Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery (1977) 1.45

Coagulation disorders in combat casualties. I. Acute changes after wounding. II. Effects of massive transfusion. 3. Post-resuscitative changes. Ann Surg (1969) 1.44

Steroid diabetes in renal transplant recipients: pathogenetic factors and prognosis. Surgery (1973) 1.43

Intra-abdominal infections in pancreas transplant recipients. Ann Surg (1986) 1.42

Suppression of lipopolysaccharide-induced macrophage nitric oxide and cytokine production in vitro by a novel lipopolysaccharide antagonist. Surgery (1994) 1.42

Thigh abscess. An uncommon presentation of intraabdominal sepsis. Am J Surg (1986) 1.41

Anatomic evidence for spontaneous closure of ventricular septal defect. Circulation (1966) 1.41

Hyperglycemic nonketotic coma after liver transplantation. Arch Surg (1972) 1.40

Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J Leukoc Biol (1993) 1.40

Uremic pericardial effusion. Treatment by catheter drainage and local nonabsorbable steroid administration. Nephron (1976) 1.39

Anti-serum to cultured human lymphoblasts: preparation, purification and immunosuppressive properties in man. Ann Surg (1969) 1.37

Isolation of Chlamydia trachomatis from the lower respiratory tract of adults. Lancet (1980) 1.37

Cure of dysgerminoma with widespread metastases appearing after renal transplantation. N Engl J Med (1970) 1.36

Cyclosporin A in renal transplantation: a prospective randomized trial. Surgery (1982) 1.36

Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity. Infect Immun (1985) 1.35

Cytomegalovirus: Clinical virological correlations in renal transplant recipients. Ann Surg (1974) 1.34

Herpes simplex virus hepatitis after solid organ transplantation in adults. J Infect Dis (1991) 1.33

Immunotherapy of cancer: immunospecific rejection of tumors in recipients of neuraminidase-treated tumor cells plus BCG. Science (1971) 1.33

Chemotactic deactivation of human neutrophils: evidence for nonspecific and specific components. Infect Immun (1978) 1.33

A central role for IL-1 beta in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. IL-1 beta induces hepatic nitric oxide synthesis. J Immunol (1995) 1.33

Pathologic anatomy of the lungs following shock and trauma. J Trauma (1968) 1.33

Effect of neuraminidase on the stimulatory capacity of cells in human mixed lymphocyte cultures. Clin Exp Immunol (1971) 1.32

Acquired immunologic deficiencies after trauma and surgical procedures. Surg Gynecol Obstet (1974) 1.30

Immunogenicity and antigenicity of lymphoid cells treated with neuraminidase. Nat New Biol (1971) 1.29

Prevention of urological complications after kidney transplantation. Ann Surg (1971) 1.29

Secondary bacterial peritonitis: the biologic basis of treatment. Curr Probl Surg (1979) 1.28

Renal transplantation in high-risk patients. Arch Surg (1971) 1.28

Chemotactic deactivation of human neutrophils: possible relationship to stimulation of oxidative metabolism. Infect Immun (1979) 1.27

Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Ann Surg (1976) 1.26

Antibiotic trials in intra-abdominal infections. A critical evaluation of study design and outcome reporting. Ann Surg (1984) 1.26

The dynamics of wound healing. Surg Gynecol Obstet (1970) 1.26

Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition. J Biol Chem (2000) 1.25

Renal transplantation in children ages 1 to 5 years. Pediatrics (1978) 1.25

Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J Leukoc Biol (1992) 1.25

Intestinal bacteria translocate into experimental intra-abdominal abscesses. Arch Surg (1986) 1.24

Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients. J Infect Dis (1984) 1.24

Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis. Surgery (1980) 1.24

The clinical use of antilymphocyte globulin. N Engl J Med (1971) 1.24

EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J Biol Chem (1992) 1.24